[1]
Ravasio, R. 2015. Economic Analysis of the Immunostimulant OM-85 for the Prevention of Paediatric Recurrent Upper Respiratory Tract Infections. Global and Regional Health Technology Assessment. 2, 3 (Sep. 2015), 135–142. DOI:https://doi.org/10.33393/grhta.2015.338.